β-defensin 10 Inhibitors
β-defensin 10 inhibitors are a class of chemical compounds that target and suppress the activity of β-defensin 10, a member of the defensin family of small cationic peptides. Defensins are known for their role in innate immunity, and β-defensin 10 is no exception, possessing antimicrobial properties. Structurally, β-defensins are characterized by a conserved cysteine-rich framework that forms stable β-sheet structures via disulfide bonds. Inhibitors of β-defensin 10 typically interact with this peptide by disrupting its molecular structure, binding to active sites, or altering its conformational stability. The mechanism of inhibition can vary depending on the nature of the inhibitor, such as small molecules, peptides, or other biochemicals that block the protein's activity. The inhibition of β-defensin 10 is important for understanding its precise biological function, especially in the context of its role in modulating specific molecular pathways.
The structural specificity of β-defensin 10 inhibitors lies in their ability to precisely target the peptide's distinctive β-sheet and looped configurations, which are stabilized by disulfide bridges. This intricate architecture requires inhibitors that can either bind to these structural motifs or disrupt their integrity, preventing β-defensin 10 from executing its typical biological functions. Detailed studies of these inhibitors often involve understanding how they interact at the molecular level with β-defensin 10's charged amino acid residues, as well as their impact on the peptide's stability and folding dynamics. Characterization of such inhibitors relies on techniques such as X-ray crystallography, NMR spectroscopy, and computational modeling to reveal the precise interactions between the inhibitor and β-defensin 10. Insights from these studies contribute to a deeper understanding of the regulatory mechanisms underlying the activity of β-defensins in various cellular environments.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Amlexanox | 68302-57-8 | sc-217630 | 10 mg | $160.00 | 2 | |
Selective inhibitor of IκB kinase (IKK), directly blocking NF-κB activation. By inhibiting IKK, it indirectly hinders DEFB10 expression, as NF-κB regulates the transcription of antimicrobial peptides, including defensins. | ||||||
Stat3 inhibitor V, stattic | 19983-44-9 | sc-202818 sc-202818A sc-202818B sc-202818C sc-202818D sc-202818E sc-202818F | 25 mg 100 mg 250 mg 500 mg 1 g 2.5 g 5 g | $130.00 $196.00 $274.00 $512.00 $731.00 $1408.00 $2091.00 | 114 | |
Inhibits signal transducer and activator of transcription 3 (STAT3), a downstream effector in the JAK-STAT pathway. Indirectly attenuates DEFB10 expression by suppressing STAT3, a transcription factor involved in antimicrobial peptide regulation. | ||||||
Resatorvid | 243984-11-4 | sc-476758 | 5 mg | $367.00 | ||
Blocks Toll-like receptor 4 (TLR4) activation, influencing the NF-κB pathway. Indirectly modulates DEFB10 by interfering with the TLR4-mediated signaling, crucial for the regulation of antimicrobial peptides, including defensins. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 mitogen-activated protein kinase (MAPK), a component in the MAPK signaling pathway. Indirectly disrupts DEFB10 expression by suppressing p38 MAPK, a kinase involved in the regulation of antimicrobial peptides, including defensins. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Blocks the activation of nuclear factor-kappa B (NF-κB), a transcription factor involved in the regulation of DEFB10. By inhibiting NF-κB, this compound directly interferes with the transcriptional control of antimicrobial peptides, including defensins. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits phosphoinositide 3-kinase (PI3K), a kinase involved in the PI3K/Akt pathway. Indirectly influences DEFB10 expression by disrupting the signaling cascade that regulates antimicrobial peptides, including defensins. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mammalian target of rapamycin (mTOR), a component in the PI3K/Akt pathway. Indirectly modulates DEFB10 expression by suppressing mTOR, a kinase crucial for the regulation of antimicrobial peptides, including defensins. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits activator protein-1 (AP-1), a transcription factor involved in the regulation of DEFB10. By blocking AP-1 activation, this compound directly interferes with the transcriptional control of antimicrobial peptides, including defensins. | ||||||
BMS-345541 | 445430-58-0 | sc-221741 | 1 mg | $312.00 | 1 | |
Inhibits the IKK complex, directly blocking NF-κB activation. By targeting IKK, it indirectly hinders DEFB10 expression, as NF-κB regulates the transcription of antimicrobial peptides, including defensins. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
Inhibits glycogen synthase kinase-3 (GSK-3), a kinase involved in the regulation of DEFB10. Indirectly modulates DEFB10 expression by suppressing GSK-3, a kinase crucial for the regulation of antimicrobial peptides, including defensins. | ||||||